Muken Ross 4

4 · SOPHiA GENETICS SA · Filed Apr 10, 2026

AI-generated summary of this filing

Updated Apr 10, 2026

SOPHiA GENETICS (SOPH) President Muken Ross Sells Shares

What Happened

Muken Ross, President of SOPHiA GENETICS SA (SOPH), sold a total of 4,736 shares in two open-market transactions to satisfy tax-withholding obligations tied to recent RSU vesting. On 2026-04-08 he sold 2,786 shares at a weighted average price of $4.84 for proceeds of $13,488; on 2026-04-09 he sold 1,950 shares at a weighted average price of $4.74 for proceeds of $9,239. Total proceeds were approximately $22,727. These sales were effected under a pre-established Rule 10b5-1 trading plan and were not discretionary.

Key Details

Transaction dates and reported weighted-average prices:
- 2026-04-08: 2,786 shares sold; weighted avg price $4.84; proceeds $13,488 (price range reported: $4.77–$4.95).
- 2026-04-09: 1,950 shares sold; weighted avg price $4.74; proceeds $9,239 (price range reported: $4.665–$4.85).
Reason: Shares sold to satisfy tax withholding from restricted stock units that vested April 2–3, 2026 (footnote F1).
Trading plan: Sales executed pursuant to a pre-established Rule 10b5-1 plan (non-discretionary) (F1).
Price detail disclosure: Weighted-average prices reported; the filer can provide the number of shares sold at each separate price within the ranges on request (F2, F3).
Filing: Report filed 2026-04-10 (covers transactions on 2026-04-08 and 2026-04-09); appears timely based on Form 4 rules.
Shares owned after the transactions: Not specified in the provided excerpt.

Context

These sales were tax-withholding related and executed under a 10b5-1 plan, which generally indicates routine, pre-planned transactions rather than discretionary insider selling. Such transactions are common following RSU vesting and do not necessarily signal the insider's view of the company's prospects.

Form 4

Period: 2026-04-08

DirectorChief Executive Officer

Transactions

Footnotes (3)

[F1]Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades.
[F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.77 to $4.95, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.665 to $4.85, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Signature

/s/ Elimara Brunetto as Attorney-in-fact for Ross Muken|2026-04-10

1 file